Resection Should be Considered for Residual Non-Retroperitoneal Disease in Post-Chemo NSGCTs

home / oncclub / resection-should-be-considered-for-residual-non-retroperitoneal-disease-in-post-chemo-nsgcts

Jennifer M. King, MD, discusses the need for improved guidance when determining the appropriate management strategy for patients with residual nonretroperitoneal testicular cancer and findings from a study on the association between the presence of teratoma in the primary orchiectomy and the rate of teratoma in this disease.